Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd. for CNY 160 million on December 15, 2022.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.85 CNY | +1.03% | +8.43% | -29.22% |
1st Jan change | Capi. | |
---|---|---|
-29.22% | 203M | |
-3.00% | 9.32B | |
-1.14% | 1.42B | |
-4.62% | 1.39B | |
-6.16% | 1.2B | |
-12.55% | 910M | |
+1.05% | 473M | |
+3.96% | 441M | |
-47.25% | 369M | |
-18.14% | 359M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for CNY 160 million.